The World Anti-Doping Program

GUIDELINES FOR URINE SAMPLE

COLLECTION

Version 5.1

August 2010

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 – August 2010
 INDEX Page

1. Objective 3

2. Scope 3

3. Definitions
3.1 Terms defined from the 2009 Code 3
3.2 Terms defined from the IST and/or Guidelines for Urine
Sample Collection 6

4. Responsibility
4.1 Doping Control Officer (DCO) 7
4.2 Chaperone 7
4.3 Athlete 8
4.4 Athlete Representative 8

5 Preparation for the Sample Collection Session

5.1 Prepare the necessary equipment 8
5.2 Brief personnel on roles and responsibilities 9
5.3 Assess the facilities 9
5.4 Athlete selection 11

6. Athlete Notification and Chaperoning

6.1 Athlete notification 12
6.2 Chaperoning the Athlete to the Doping Control Station 15
6.3 Arrival at the Doping Control Station 16

7. Conducting the Sample Collection Session

7.1 Selection of the Sample collection vessel 17
7.2 Sample provision 17
7.3 Insufficient volume 18
7.4 Dividing and sealing the Sample 19
7.5 Samples not meeting laboratory guidelines for analysis 20
7.6 Paperwork 21
7.7 Sample storage 22

8. Transport of Samples and Documentation

8.1 Transportation of Samples 23
8.2 Hand-over of Samples to the laboratory 23
8.3 Documentation 23

9. Modifications for Minors and Athletes with a Disability

9.1 Overview 23
9.2 Minors 24
9.3 Athletes with a disability 24
9.4 Athletes using condom drainage/indwelling
catheter drainage 25
9.5 Athletes who self-catheterize 25

Appendix1 Chaperone Training Guidelines 26

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 2 of 27
1. Objective

This guideline expands upon the International Standard for Testing and details the
recommended process for the collection of urine for Doping Control purposes, both In-
Competition and Out-of-Competition. The guideline includes on-site preparation, Sample
collection and post-test administration.

With the exception of those mandatory areas which are part of the World Anti-Doping
Program, the processes outlined in this document are not mandatory, but are aimed at
assisting Anti-Doping Organizations in the development of systems and protocols for
urine Sample collection. The method of Sample collection may vary from these
recommendations in some circumstances; however, minimum standards shall apply to
ensure that the integrity of the Sample is maintained in accordance with the mandatory
provisions of the International Standard for Testing.

2. Scope

This Guideline begins with the arrival of Sample Collection Personnel at the Doping
Control Station, and ends with the dispatch of the urine Sample to the laboratory.

3. Definitions

3.1 Defined terms from the 2009 Code

ADAMS: The Anti-Doping Administration and Management System is a Web-based

database management tool for data entry, storage, sharing, and reporting designed
to assist stakeholders and WADA in their anti-doping operations in conjunction with
data protection legislation.

Anti-Doping Organization (ADO): A Signatory that is responsible for adopting

rules, for initiating, implementing or enforcing any part of the Doping Control process.
This includes, for example, the International Olympic Committee, the International
Paralympic Committee, other Major Event Organizations that conduct Testing at their
Events, WADA, International Federations, and National Anti-Doping Organizations.

Athlete: Any Person who participates in sport at the international level (as defined
by each International Federation), the national level (as defined by each National
Anti-Doping Organization, including but not limited to those Persons in its Registered
Testing Pool), and any other competitor in sport who is otherwise subject to the
jurisdiction of any Signatory or other sports organization accepting the Code. All
provisions of the Code, including, for example, Testing and therapeutic use
exemptions, must be applied to international- and national-level competitors. Some
National Anti-Doping Organizations may elect to test and apply anti-doping rules to
recreational-level or masters competitors who are not current or potential national
caliber competitors. National Anti-Doping Organizations are not required, however,
to apply all aspects of the Code to such Persons. Specific national rules may be

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 – August 2010
 established for Doping Control for non-international-level or non-national-level
competitors without being in conflict with the Code. Thus, a country could elect to
test recreational-level competitors but not require therapeutic use exemptions or
whereabouts information. In the same manner, a Major Event Organization holding
an Event only for masters-level competitors could elect to test the competitors but
not require advance therapeutic use exemptions or whereabouts information. For
purposes of Article 2.8 (Administration or Attempted Administration) and for
purposes of anti-doping information and education, any Person who participates in
sport under the authority of any Signatory, government, or other sports organization
accepting the Code is an Athlete.

[Comment: This definition makes it clear that all international- and national-caliber athletes
are subject to the anti-doping rules of the Code, with the precise definitions of international-
and national- level sport to be set forth in the anti-doping rules of the International
Federations and National Anti-Doping Organizations, respectively. At the national level, anti-
doping rules adopted pursuant to the Code shall apply, at a minimum, to all persons on
national teams and all persons qualified to compete in any national championship in any
sport. That does not mean, however, that all such Athletes must be included in a National
Anti-Doping Organization’s Registered Testing Pool. The definition also allows each National
Anti-Doping Organization, if it chooses to do so, to expand its anti-doping program beyond
national-caliber athletes to competitors at lower levels of competition. Competitors at all
levels of competition should receive the benefit of anti-doping information and education.]

Code: The World Anti-Doping Code.

Competition: A single race, match, game or singular athletic contest. For example, a
basketball game or the finals of the Olympic 100-meter dash. For stage races and
other athletic contests where prizes are awarded on a daily or other interim basis the
distinction between a Competition and an Event will be as provided in the rules of the
applicable International Federation.

Doping Control: All steps and processes from test distribution planning through to
ultimate disposition of any appeal including all steps and processes in between such
as provision of whereabouts information, Sample collection and handling, laboratory
analysis, therapeutic use exemptions, results management and hearings.

Event: A series of individual Competitions conducted together under one ruling body
(e.g., the Olympic Games of the Olympiad and the Winter Games, the FINA World
Championships, or Pan American Games).

In-Competition: Unless provided otherwise in the rules of an International

Federation or other relevant Anti-Doping Organization, “In-Competition” means the
period commencing twelve hours before a Competition in which the Athlete is
scheduled to participate through the end of such Competition and the Sample
Collection process related to such Competition.

International Standard: A standard adopted by WADA in support of the Code.

Compliance with an International Standard (as opposed to another alternative
standard, practice or procedure) shall be sufficient to conclude that the procedures

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 4 of 27
 addressed by the International Standard were performed properly. International
Standards shall include any Technical Documents issued pursuant to the International
Standard.

Minor: A natural Person who has not reached the age of majority as established by
the applicable laws of his or her country of residence.

National Anti-Doping Organization: The entity(ies) designated by each country as

possessing the primary authority and responsibility to adopt and implement anti-
doping rules, direct the collection of Samples, the management of test results, and
the conduct of hearings, all at the national level. This includes an entity which may be
designated by multiple countries to serve as regional Anti-Doping Organization for
such countries. If this designation has not been made by the competent public
authority (ies), the entity shall be the country’s National Olympic Committee or its
designee.

National Olympic Committee (NOC): The organization recognized by the

International Olympic Committee. The term National Olympic Committee, shall also
include National Sport Confederation in those countries where the National Sport
Confederation assumes typical National Olympic Committee responsibilities in the
anti-doping area.

No Advance Notice: A Doping Control which takes place with no advance warning
to the Athlete, and where the Athlete is continuously chaperoned from the moment of
notification through Sample provision.

Out- of-Competition: Any Doping Control which is not In-Competition.

Registered Testing Pool: The pool of top level Athletes established separately be
each International Federation and National Anti-Doping Organization who are subject
to both In-Competition and Out-of-Competition Testing as part of that International
Federation’s or Organization’s Test Distribution Plan. Each International Federation
shall publish a list which identifies those Athletes included in its Registered Testing
Pool either by name or by clearly defined, specific criteria.

Sample: Any biological material collected for the purposes of Doping Control.

Target Testing: Selection of Athletes for Testing where specific Athletes or groups of
Athletes are selected on a non-random basis for Testing at a specified time.
Team Sport: A sport in which the substitution of players is permitted during a
Competition.

Testing: The parts of the Doping Control process involving test distribution planning,
Sample collection, Sample handling and Sample transport to the laboratory.

TUE: A Therapeutic Use Exemption (see International Standard for Therapeutic Use
Exemptions).

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 5 of 27
 WADA: The World Anti-Doping Agency.

3.2 Defined terms from the IST and/or Guidelines for Urine Sample Collection

Athlete Representative: A person designated by the Athlete to assist with the

verification of the Sample collection procedure, (not including the passing of the
Sample). This person may be a member of the Athlete’s support personnel, such as a
coach or team doctor, a family member, or other.

Chaperone: An official who is trained and authorized by the ADO to carry out specific
duties including one or more of the following: notification of the Athlete selected for
Sample collection; accompanying and observing the Athlete until arrival at the Doping
Control Station; and/or witnessing and verifying the provision of the Sample where
the training qualifies him/her to do so.

Chain of Custody: The sequence of individuals or organizations who have the

responsibility for a Sample from the provision of the Sample until the Sample has
been received for analysis.

Doping Control Officer (DCO): An official who has been trained and authorized by
the ADO with delegated responsibility for the on-site management of a Sample
Collection Session.

Doping Control Station: The location where the Sample Collection Session will be
conducted.

Sample Collection Equipment: Containers or apparatus used to directly collect or

hold the Sample at any time during the Sample collection process. Sample Collection
Equipment shall, as a minimum, consist of:

 For urine Sample collection:

- Collection vessels for collecting the Sample as it leaves the Athlete’s body;
- Sealable and tamper-evident bottles and lids for securing the Sample;
- Partial Sample kit.

Sample Collection Personnel: A collective term for qualified officials authorized by

the ADO who may carry out or assist with duties during the Sample Collection Session.

Sample Collection Session: All of the sequential activities that directly involve the
Athlete from notification until the Athlete leaves the Doping Control Station having
provided his/her Samples(s).

Suitable Specific Gravity for Analysis: Specific gravity measured at 1.05 or higher
with a refractometer, or 1.010 or higher with lab sticks.

Suitable Volume of Urine for Analysis: A minimum of 90 mL for full or part menu
analysis.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 6 of 27
 Test Distribution Plan: As defined in Clause 4.2.1 of the International Standard for
Testing.

Whereabouts Filing: Information provided by or on behalf of an Athlete in a

Registered Testing Pool that sets out the Athlete’s whereabouts during the following
quarter, in accordance with Clause 11.3 of the International Standard for Testing (or
optionally, in the case of a Team Sport, in accordance with Clause 11.5 of the
International Standard for Testing).

Witness: The member of Sample Collection Personnel who observes the passing of
the Sample by the Athlete in accordance with the procedures for observation.

4. Responsibility

4.1 Doping Control Officer (DCO)

(One lead/senior DCO should take responsibility for Sample collection services)

 Organize and brief Sample Collection Personnel.

 Ensure that Chaperones are trained in carrying out relevant activities.
 Liaise with sport representatives, if relevant.
 Organize equipment, including all relevant documentation.
 Assess and organize the facilities.
 Arrange or perform notification and escorting of Athletes.
 Ensure that the Athlete’s rights and responsibilities are explained.
 Explain, or arrange explanation of, the process for urine Sample collection
to Athletes and Athlete Representatives, as necessary.
 Witness, or arrange the witnessing of, Sample provision.
 Co-ordinate collection of accompanying blood Sample if necessary.
 Complete, or arrange completion of, and verify, the relevant paperwork.
 Verify the Chain of Custody.
 Organize courier services, if necessary.

4.2 Chaperone

 Notify the Athlete in person as instructed by the DCO.

 Escort the Athlete from notification until arrival at the Doping Control
Station.
 If appropriately trained and authorized (see Appendix 1), act as the Witness
for Sample provision as instructed by the DCO and complete the relevant
section of the Doping Control documentation as instructed by the DCO.
 NOTE: Some Anti-Doping Organizations prefer that Chaperones do not
witness Sample provision but conduct Athlete notification only. These
Guidelines allow for both these scenarios.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 7 of 27
4.3 Athlete

 Request the presence of an Athlete Representative, if desired.

 Report for Doping Control as soon as possible, and within the specified time
frame.
 Be escorted from notification to Sample provision.
 Be responsible for any food or beverage consumed prior to Sample provision.
 Be familiar with the Sample collection process.
 Be responsible at all times for his/her own Sample(s) from provision to final
sealing.
 Observe the procedure and ensure there are no irregularities.
 Declare any medication use as specified on the Doping Control
documentation.
 Provide a TUE certificate if applicable.
 Make comments relating to the Sample collection process on the Doping
Control documentation, if applicable.
 Sign documentation as requested by the DCO.

4.4 Athlete Representative

(Presence optional, at Athlete’s request)

 Accompany the Athlete during notification.

 Accompany the Athlete to the Doping Control Station.
 Assist in the selection of equipment and the sealing process where asked to
do so by the Athlete.
 Assist the Athlete in the completion of paperwork where asked to do so by
the Athlete.
 Be familiar with the Sample collection process.
 Observe the Sample collection process and ensure there are no
irregularities.
 Sign documentation as requested by the DCO.

5. Preparation for the Sample Collection Session

Preparation for the Sample Collection Session is divided into the following steps:

5.1 Prepare the necessary equipment

5.1.1 The DCO shall ensure equipment and supplies are adequate for the Sample
Collection Session. The type of equipment may vary but, as a guideline, the
following will be made available:

 Sealed, sterile urine collection vessels.

 Partial Sample kits.
 Equipment for measuring specific gravity.
 Sealed, tamper-evident containers for A and B Samples.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 8 of 27
  Sealed, tamper-evident transport containers (if applicable).
 Secure courier transport bags.
 Disposable gloves
 Soap or hand wash
 Paper towels
 Garbage bin or similar for disposal
 Individually sealed non-alcoholic beverages
 All Doping Control documentation, including Doping Control forms, Athlete
notification forms, supplementary report forms, Chain of Custody forms,
DCO Report Forms etc.

[5.1.1 Comment: Sufficient Sample Collection Equipment shall be made available to ensure that
at all times an Athlete selected for Testing has a choice of at least two Sample collection vessels,
Sample collection kits and Partial Sample kits. Furthermore sufficient Doping Control
documentation should be supplied based upon the number of tests being conducted.]

5.1.2 Any Sample Collection Equipment systems used shall meet the following
minimum criteria:
 Have unique numbering systems incorporated into all bottles, containers or
other item used to seal the Sample.
 Have a sealing system that is tamper evident.
 Ensure the identity of the Athlete is not evident from the equipment itself
 Ensure that all equipment is clean and sealed prior to use by the Athlete.

5.2 Brief personnel on roles and responsibilities

5.2.1 The DCO should brief the Sample Collection Personnel on their roles and
responsibilities prior to or upon arrival at the Doping Control Station. This will
include Athlete notification, chaperoning, and Sample collection (including
blood collection if applicable).

5.2.2 In the case of a team which includes Chaperones with no experience, the DCO
shall train the Chaperones on-site. Such training shall include the
requirements for notification, chaperoning and witnessing Sample provision, as
well as confidentiality obligations (see Appendix 1 for Chaperone Training
Guidelines).

5.2.3 The DCO shall provide required documentation such as proof of authority to
conduct Sample collection, to the Sample Collection Personnel if applicable.

[5.2.3 Comment: It is the responsibility of the ADO to provide and control the official
authorization documentation used. Doping Control Authorization letters can be automatically
generated from ADAMS. The DCO may be responsible for distributing the official authorization
documentation to all Sample Collection Personnel.]

5.3 Assess the facilities

5.3.1 The minimum requirements to be met to enable use of a facility as a Doping

Control Station are privacy and sole-use. If the facility does not offer the

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 9 of 27
 Athlete privacy, and/or is intended to be used for purposes other than Doping
Control whilst Sample collection is being carried out, the DCO may decide not
to proceed with Testing. The reasons for such a decision must be documented.

[5.3.1 Comment: ADOs may wish to request DCOs to include a sketch of the Doping Control
Station in their DCO report.]

5.3.2 For In-Competition Testing, where possible, the Doping Control Station shall at
a minimum ensure the Athlete’s privacy and should meet the following criteria:

 Be solely reserved for Doping Control purposes

 Maintain Athlete privacy and confidentiality
 Be accessible only to authorized personnel
 Be secure enough to store Sample Collection Equipment
 Be comprised of a waiting area with chairs and a separate administration
area with a table and chairs for completion of paperwork. There should be
adjacent toilet facilities for Sample provision, which should ideally consist of
cubicles large enough for the Witness and the Athlete.
 Include facilities to allow the Athlete to wash his/her hands.
 Be large enough to accommodate the number of Athletes, Athlete
Representative Sample Collection Personnel who will occupy the area
 Be suitably located in relation to the field of play or other location where
Athletes will be notified.
 Contain, where possible, a selection of sealed, non-alcoholic drinks for
Athletes.

[5.3.2 Comment: In order to ensure efficiency of Athlete notification and chaperoning, the DCO
should consider the location of the Doping Control Station. For some sporting venues, the Doping
Control Station may be some distance from where the Athletes compete/finish. In such cases the
DCO should seek to arrange appropriate transportation for Athletes and Sample Collection
Personnel. Alternatively, the DCO should seek to locate the Doping Control Station closer to
where the Athletes compete/finish their Competition.]

5.3.3 For Out-of-Competition Testing, the facilities used should, where possible,
provide a suitable environment for waiting and administration, and shall afford
the Athlete privacy.

[5.3.3 Comment: Although the term ‘Doping Control Station’ is also used for Out-of-Competition
Testing, this facility might be an Athlete’s home or a hotel room, rather than an officially
designated facility for Doping Control.]

5.3.4 Access to the Doping Control Station is restricted to the Athlete, the Athlete
Representative, an interpreter if required, and Sample Collection Personnel,
unless otherwise agreed by the DCO. Additional personnel requesting access
may include an IF representative, an ADO observer, an auditor or a WADA
Independent Observer. These personnel should have adequate authorization
available for the DCO to review upon arrival at the Doping Control Station.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 10 of 27
 5.3.5 The DCO may wish to assign a member of the Sample Collection Personnel to
monitor access to the Doping Control Station, and ensure that only
unauthorized persons are admitted.

5.3.6 Members of the media must not be allowed to enter the Doping Control Station
at any time.

5.4 Athlete selection

5.4.1 The DCO will select Athletes according to the selection policy indicated by the
ADO. This may include one or both of the following: Target Testing (named
Athletes or categories) random selection.

[5.4.1 Comment: Selections/selection methods made by the ADO should be clearly communicated
to the DCO. For example, detailing selections in an ADAMS mission order.]

5.4.2 In the case of random selection, the ADO/DCO may choose to use one of the
following selection criteria. The criteria chosen should be appropriate for the
sport, e.g.:

 Finishing position
 Vest/jersey number
 Entry number
 Lane number
 Any other fair and transparent criteria for selection

Once the criteria have been determined, the actual selection method may be
one of the following:

 Numbered cards placed face-down on a table

 Random draw of numbers (or names) from a closed container such as a
cloth bag
 Use of an electronic random number generator
 Any other fair and transparent method of selection

[5.4.2 Comment: In order to provide transparency and accountability, random selection made in
the field may be witnessed by a coach or sporting official, or may be shown to the selected
Athlete if requested. For example a signature on the back of numbered cards. In addition to
determining the selection criteria, the DCO/ADO may wish to put in place certain contingencies for
specific scenarios. For example, randomly drawing an additional ‘reserve’ Athlete to be tested in
the event that a serious injury inhibits an Athlete from conducting Doping Control. Another
example includes putting a contingency in place for ‘dead-heats’ or disqualifications. All
contingencies put in place should be fully briefed to all relevant Sample Collection Personnel.]

5.4.3 In the case of Target Testing, the ADO will specify to the DCO which Athletes
they require for Testing. In some instances, the ADO may chose to give the
DCO discretion to decide additional Athletes selected for Target Testing.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 11 of 27
[5.4.3 Comment: See the International Standard for Testing, 4.4.2, for factors which an ADO
should consider when selecting Athletes for Target Testing. If the ADO chooses to provide the
DCO with the discretion to target Athletes for Testing, this should be agreed prior to the Sample
Collection Session taking place and comprehensive guidance should be provided by the ADO to
the DCO. Factors that may wish to be considered for such Target Testing include suspicious
Athlete behavior. The DCO should not discuss Target Testing or the selection criteria with an
Athlete.]

5.4.4 Following the selection of the Athlete, the DCO shall ensure that selection
decisions are disclosed on a need-to-know basis only to ensure that Testing is
No Advance Notice.

6. Athlete Notification and Chaperoning

6.1 Athlete notification

6.1.1 The DCO/Chaperone shall establish the location of the selected Athlete, and
plan the approach and timing of notification, taking into account any specific
circumstances such as the Competition/training schedule, and such that the
notification will be carried out as No-Advance-Notice notification.

[6.1.1 Comment: The DCO should take into consideration all logistical factors, be it venue-specific,
sport-specific etc, when planning the appropriate timing and approach for Athlete notification.
Some factors to consider (this list is not exhaustive) include; challenges faced in sports with mass
finishes, the presence of a Mixed Zone at the venue, using Technical Delegates to assist in the
identifying/confirming final positions, sports where it is common that Athletes are Minors and/or
have a disability that may require a third party present during notification. All relevant factors
should be communicated to all Sample Collection Personnel.]

6.1.2 The DCO/Chaperone shall identify him/herself and shall show the Athlete the
official authorization documentation that is provided and controlled by the ADO
which has granted the authority to test. Additional photo identification proving
affiliation to the authorized Sample collection authority shall also be provided,
if this authority is not the ADO which authorized the test. DCO identification
documents shall include name, photograph, and the documents’ expiry date.
Chaperones do not require documentation identifying them by name or
photograph but as a minimum shall produce official authorization
documentation that is provided by the ADO, such as an Authorization Letter.

6.1.3 It is the DCO/Chaperone’s responsibility to ensure that the Athlete is the first
one notified that he/she has been selected for Sample collection. Only in the
following instances may there be an exception to this:

 Where the Athlete is a Minor, has a disability and/or where an interpreter is

needed and the ADO/DCO/Chaperone consider it a requirement to notify a
third party prior to the notification of the Athlete.
 Where the DCO/Chaperone requires assistance in locating, identifying
and/or notifying the Athlete(s) selected for Testing.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 12 of 27
[6.1.3 Comment: In some Sample Collection Sessions, for example In-Competition Testing or
Testing at training camps, the DCO/Chaperone may require assistance from a third party, for
example a sport representative, in locating and identifying certain Athletes. This may be due to
the DCO/Chaperone being unfamiliar with the Athlete or the venue at which the Sample Collection
Session is taking place.]

In both these cases, it is still the DCO/Chaperone who should conduct the notification of
the Athlete.

6.1.4 The DCO/Chaperone shall, at a minimum, verbally confirm the Athlete’s

identity. If the Athlete is carrying photo ID, this may be checked at this stage.
An Athlete’s inability to provide photo ID shall not invalidate a test. Formal
identification can be established by starting number, accreditation, third party
witness, or other viable method as established by the ADO. If the Athlete’s
identity is unknown and cannot be established in any manner, the DCO must
contact the ADO for further instructions.

6.1.5 The DCO/Chaperone should show the Athlete the notification form (which may
be part of the Doping Control form), and shall then notify the Athlete of the
following:

 That the Athlete is required to undergo a Sample collection

 The authority under which Sample collection is to be conducted(i.e. the
Testing Authority)
 The type of Sample Collection (i.e. urine, blood or both) and any conditions
that need to be adhered to prior to Sample collection, including the
requirement for the Athlete to provide their Sample in direct observation of
a DCO/Chaperone.
 The Athlete’s rights, including the right to:
- Have an Athlete Representative present throughout the course of the
entire Sample collection process (other than Sample provision) and if
available, an interpreter.
- Ask for additional information about the Sample collection process.
- Request a delay in reporting to the Doping Control Station for valid
reasons (see 6.1.11 for what constitutes valid reasons).
- Request modifications to the Sample collection procedure if the
Athlete has a disability (see section 9)
 The Athlete’s responsibilities, including the requirement to:
- Remain within direct observation of the DCO/Chaperone at all times
from the point of notification by the DCO/Chaperone until the
completion of the Sample collection process.
- Produce appropriate and valid identification in accordance with 6.1.4.
- Comply with the Sample collection procedures (and the Athlete
should be advised of the possible consequences of Failure to Comply)
- Report immediately for a test, unless there are valid reasons for a
delay, as determined by the DCO.
 The location of the Doping Control Station.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 13 of 27
  That should the Athlete choose to consume food or fluids prior to providing
a Sample, he/she does so at his/her own risk, and should in any event
avoid excessive rehydration, having in mind the requirement to produce a
Sample with a Suitable Specific Gravity for Analysis.
 That the Sample provided by the Athlete to the Sample Collection Personnel
should be the first urine passed by the Athlete subsequent to notification,
i.e. he/she should not pass urine in the shower or otherwise prior to
providing a Sample to the Sample Collection Personnel.

[6.1.5 Comment: (i) The Testing Authority is the Anti-Doping Organisation that has initiated and
authorized the Sample Collection Session. (ii) For requirements specific to blood Sample collection,
refer to the Guidelines for Blood Sample Collection.]

6.1.6 The DCO/Chaperone should encourage the presence of a third party during the
notification process where the Athlete is a Minor, it is required by an Athlete’s
disability or in situations where an interpreter is required.

6.1.7 If a selected Athlete is not located based on available information, the DCO
may attempt to locate the Athlete by other means, but ensure that No
Advance Notice notification is used as a notification method. The DCO should
notify the ADO for further instructions if the Athlete is not located.

[6.1.7 Comment: In the event that a DCO is unable to locate an Athlete based on the available
information, the DCO should in most cases (for e.g. for In-Competition Testing) attempt to locate
the Athlete by other means. If the DCO is attempting to locate the Athlete for an Out-of-
Competition test, during a specific 60-minute time slot as designated in the Athlete’s
Whereabouts Filing, the DCO shall follow the procedures set out in the International Standard for
Testing 11.4.3 (b) & (c). Under no circumstances shall the DCO/Chaperone make a telephone call
to the Athlete to locate them.]

6.1.8 The Athlete shall read and sign the Athlete notification form or Doping Control
form as directed by the DCO/Chaperone.

6.1.9 If an Athlete copy of the official notification record exists, this will be given to
the Athlete.

6.1.10 If the Athlete refuses to sign that he/she has been notified, or evades
notification, the DCO/Chaperone shall make all reasonable attempts to
persuade the Athlete to comply, including informing the Athlete again of the
consequences of refusing or failing to comply. If the Athlete continues to
refuse, the DCO/Chaperone must report all the relevant facts to the DCO
immediately, and the DCO shall attempt to notify the Athlete. If the Athlete
still refuses to be notified, the DCO shall document the facts, including the
reasons for refusal given by the Athlete. The DCO should endeavor to obtain
Witness signatures to confirm the Athlete’s refusal, and shall contact the ADO
for further instructions as soon as possible.

6.1.11 The DCO may at their discretion consider any reasonable third party
requirement or any request by the Athlete for permission to delay reporting to

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 14 of 27
 the Doping Control Station following acknowledgment and acceptance of
notification; and/or to leave the Doping Control Station temporarily after
arrival. Such permission shall only be granted if the Athlete can be
continuously chaperoned and kept under direct observation during the delay
and if the request relates to the following activities:

For In-Competition Testing:

 Participation in a victory ceremony
 Fulfillment of media commitments
 Competing in further Competitions
 Performing a warm down
 Obtaining necessary medical treatment
 Locating a representative and/or interpreter
 Obtaining photo identification
 Any other exceptional circumstances which may be justified, and which shall
be documented

For Out-of-Competition Testing:

 Locating an Athlete Representative.
 Completing a training session
 Receiving necessary medical treatment
 Obtaining photo identification
 Any other exceptional circumstances which may be justified, and which shall
be documented.

6.1.12 The DCO shall document any reasons for delay in reporting to the Doping
Control Station and/or reasons for leaving the Doping Control Station that may
require further investigation by the ADO. Any failure of the Athlete to remain
under constant observation shall also be recorded.

6.2 Chaperoning the Athlete to the Doping Control Station

6.2.1 The DCO/Chaperone shall ensure that the Athlete is escorted from the place of
notification to the Doping Control Station under constant supervision.

[6.2.1 Comment: The DCO should take into consideration relevant sport-specific and venue
specific factors that could affect the chaperoning process, for example sports in which Athletes
often compete in more than one Event potentially prolonging the chaperoning process.]

6.2.2 The DCO/Chaperone should discourage the Athlete from taking a bath or
shower, and should ensure he/she does not urinate prior to reporting at the
Doping Control Station. The first urine Sample post notification should be
collected.

6.2.3 The DCO/Chaperone cannot prevent the Athlete eating or drinking products of
their choice, but should recommend that the Athlete chooses from a selection
of individually sealed, non-alcoholic beverages in order to hydrate. The
DCO/Chaperone should not handle food or drink items for the Athlete.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 15 of 27
 6.2.4 The DCO/Chaperone shall escort the Athlete at all times until the Sample
collection procedures have been completed, or shall ensure that another
DCO/Chaperone has taken over escorting the Athlete.

6.2.5 The Chaperone shall inform the DCO as soon as practical without leaving the
Athlete unattended, and ensuring discretion, of any irregularities in notification
and/or suspicious Athlete behavior during the observation period. Irregularities
shall be documented by the DCO if relevant.

[6.2.5 Comment: The ADO is responsible for establishing guidelines for what constitutes
suspicious Athlete behavior – examples might be; evading observation, ingesting an unidentified
substance, a distressed call to a coach or other unusual behavior.]

6.3 Arrival at the Doping Control Station

6.3.1 The Athlete arrives at the Doping Control Station with a DCO/Chaperone and, if
requested, an Athlete Representative and/or interpreter. At this time, the
Athlete should present photo ID to the DCO. An Athlete’s inability to provide
photo ID shall not invalidate a test. Alternative methods of Athlete
identification are outlined in 6.1.4.

6.3.2 An entry and exit log should be maintained to record the names of the persons
entering facility, their position, and the times of arrival and departure.

6.3.3 The Athlete shall be provided with the opportunity to hydrate.

6.3.4 If the Athlete is providing a blood Sample at the same session, the DCO may
request that the Athlete provide the blood Sample first.

6.3.5 Irrespective of the Testing type, once the Athlete has arrived at the Doping
Control Station he/she must be under observation at all times until Sample
collection is completed.

6.3.6 The Athlete may request to leave the Doping Control Station for a time, for
reasons defined in 6.1.11. The Athlete must be escorted continuously at such
times, and the purpose of leaving, agreed time of return, and actual time of
return shall be documented by the DCO. If a Chaperone is not available, the
DCO shall ask the Athlete to remain in the Doping Control Station. If an
Athlete insists on leaving the Doping Control Station, the circumstances shall
be documented by the DCO.

6.3.7 Before Sample collection, the DCO should ask the Athlete whether they have
been tested before, and whether they require an explanation of the collection
procedure.

6.3.8 If the Athlete has not been tested before, or requests an explanation of the
procedure, the DCO should explain the Sample collection procedure to the
Athlete.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 16 of 27
 6.3.9 As a minimum, the DCO shall ensure the Athlete is informed of the
requirements of the Sample Collection Session and his/her rights and
responsibilities

7. Conducting the Sample Collection Session

7.1 Selection of the Sample collection vessel

7.1.1 The Athlete shall be given a choice of Sample collection vessels, from which
they will be asked to choose one. It is recommended that there are at least
three Sample collection vessels from which to choose.
7.1.2 The Athlete shall check that the equipment is clean and intact. If the Athlete is
not satisfied with the equipment, they should make another selection.

7.1.3 If the Athlete is not satisfied with any of the equipment, and the DCO does not
agree with the Athlete’s opinion that all of the available equipment is
unsatisfactory, the DCO shall instruct the Athlete to proceed with the Sample
Collection Session and the Athlete’s views must be recorded on the Doping
Control documentation by the DCO.

7.1.4 If both the DCO and the Athlete agree that none of the equipment is
satisfactory, the DCO shall terminate Sample collection, and record the
reasons.

7.1.5 From this point, the Sample collection vessel shall be handled only by the
Athlete unless the Athlete authorizes the DCO/Chaperone or the Athlete
Representative to handle the vessel on his/her behalf. Such authorization
must be documented.

7.2 Sample provision

7.2.1 The Witness (DCO or Chaperone) shall escort the Athlete to the toilet facility.
The Athlete will carry his/her own Sample collection vessel.

7.2.2 The Witness shall be of the same gender as the Athlete providing the Sample.

7.2.3 Where practicable, the DCO should ensure the Athlete thoroughly washes
his/her hands before providing a Sample.

7.2.4 Once in the toilet facility the Athlete must remove all clothing between the
waist and mid-thigh, in order that the witnessing Sample Collection Personnel
has an unobstructed view of Sample provision. Sleeves should be rolled up so
that the Athlete’s arms and hands are also clearly visible.

7.2.5 The Witness shall directly observe the Athlete provide the urine Sample,
adjusting his/her position so as to have a clear view of the Sample leaving the
Athlete’s body.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 17 of 27
 7.2.6 The DCO shall verify, in full view of the Athlete, that the Suitable Volume of
Urine for Analysis has been provided.

7.2.7 Once a urine Sample of at least 90mL has been collected, or the Athlete has
provided a partial Sample and is unable to provide any more urine at this time,
the Witness shall escort the Athlete, who shall carry his/her own Sample, back
to the administration area. The Athlete should be encouraged to provide as
much volume as possible and Sample Collection Personnel should note where
an Athlete makes attempts to provide only the bare minimum.

7.2.8 If an Athlete wishes to wash his/her hands after passing the Sample, the
Sample shall at this time be placed in a safe and secure location, in full view of
both the Athlete and the Witness.

7.2.9 If the Witness observes any unusual behavior by the Athlete while witnessing
the passing of the Sample, this shall be reported to the DCO as soon as
possible, and documented.

7.2.10 The Witness shall sign the relevant documentation to verify that he/she
witnessed Sample provision in accordance with procedures.

7.3 Insufficient volume

7.3.1 In the event that an Athlete is unable to provide 90 mL of urine, the DCO shall
follow the procedure for a partial Sample.

7.3.2 The DCO shall advise the Athlete that the partial Sample provided shall be
secured and a further Sample collected.

7.3.3 The DCO shall instruct the Athlete to select partial Sample Collection
Equipment, as per 7.1. It is recommended that there are at least three partial
Sample kits from which to choose.

7.3.4 The DCO shall then instruct the Athlete to open the relevant equipment, pour
the insufficient Sample into the container, and seal it as directed by the DCO.
The DCO shall check, in full view of the Athlete, that the container has been
properly sealed.

7.3.5 The DCO and the Athlete shall check that the equipment code number and the
volume and identity of the insufficient Sample are recorded accurately by the
DCO. The Athlete and DCO may initial or sign the documentation to show they
are satisfied with the procedure.

7.3.6 The Athlete should return to the waiting area, and shall remain under
observation until ready to provide a further Sample.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 18 of 27
 7.3.7 Either the Athlete or the DCO shall retain control of the Sample. The DCO shall
ensure that the sealed partial Sample is securely stored (under continuous
observation or locked away in a secure area). If the Athlete retains possession
of the Sample, it must be placed in a secure area, and must remain under the
observation of Sample Collection Personnel.

7.3.8 When the Athlete is ready to provide more urine, the Sample provision process
shall recommence.

7.3.9 To ensure continuity of the process, and for the comfort of the Athlete, the
Witness should be the same Witness as for the initial attempt, whenever
possible. However, a change of Witness shall in no way affect the integrity of
the process.

7.3.10 The Athlete shall select a new Sample collection vessel, and repeat the
process as per 7.1.

7.3.11 This process shall be repeated until the DCO is satisfied that the Athlete has
provided the required volume of urine once the initial and additional Samples
are combined.

7.3.12 The DCO shall ask the Athlete to inspect their partial Sample(s) to ensure that
the seals are secure. Any irregularities shall be recorded by the DCO on the
Doping Control documentation or in a separate report to the ADO.

7.3.13 The DCO shall then direct the Athlete to break the seal of the partial Sample
container(s) and combine the Samples in a new collection vessel, beginning
with the first partial Sample provided and each subsequent partial Sample until
the desired volume is reached.

7.3.14 Once a minimum of 90 mL of urine has been collected, the DCO and Athlete
shall proceed to the next stage.

7.4 Dividing and sealing the Sample

7.4.1 The Athlete shall select, from a choice of urine kits, a kit consisting of A and B
containers, in which the Sample is to be sealed. It is recommended that there
are at least three urine kits from which to choose.

7.4.2 The Athlete and DCO should check that the urine kit is clean and intact. If
neither the Athlete nor the DCO is satisfied with the urine kit(s), the Athlete
shall make another selection.

7.4.3 If the Athlete is not satisfied with any of the urine kits, and the DCO does not
agree with the Athlete’s opinion that all of the available urine kits are
unsatisfactory, the DCO shall instruct the Athlete to proceed with the Sample
Collection Session, and the Athlete’s views must be recorded on the Doping
Control documentation by the DCO.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 19 of 27
 7.4.4 If both the DCO and the Athlete agree that none of the urine kits are
satisfactory, the DCO shall terminate the session, and record the reasons.

7.4.5 The Athlete and the DCO shall check the urine kit to ensure that all the
numbers of the A and B containers correspond.

7.4.6 If the numbers do not correspond, the DCO shall instruct the Athlete to select
another kit. The DCO shall document this.

7.4.7 The DCO shall record the urine kit numbers and the Athlete and the DCO shall
check the documentation to ensure that the DCO has accurately recorded the
numbers of the A and B containers.

7.4.8 The Athlete shall pour the required minimum volume of urine into the B
container. The recommended amount is a minimum of 30mL.

7.4.9 The Athlete shall pour the remainder of the urine into the A container. The
recommended amount is a minimum of 60mL. If the A container is filled to
capacity the Athlete shall then pour any remaining urine into the B container,
always leaving a residual amount of urine in the collection vessel.

7.4.10 The DCO shall instruct the Athlete in the sealing of the A and B containers.
Both the DCO and the Athlete shall check that the bottles are securely sealed.

7.4.11 The DCO shall confirm that the Sample meets the requirements for analysis, as
specified by the ADO in accordance with the laboratory standards, by testing
the residual volume of urine remaining in the collection vessel for specific
gravity (greater than or equal to 1.005 if using a refractometer, or 1.010 with
lab sticks. Reagent strips and/or a refractometer may be used.

7.4.12 The DCO shall ensure that any residual urine that will not be sent for analysis
is discarded in full view of the Athlete.

7.5 Samples not meeting laboratory guidelines for analysis

7.5.1 If the reading is outside the required range for specific gravity the DCO shall
request collection of additional Sample(s).

7.5.2 Additional Samples shall be collected until the Athlete has provided a Sample
within the required range for specific gravity, unless exceptional circumstances
prevail. It is the responsibility of the ADO to determine what constitutes
exceptional circumstances whereby no further Samples shall be collected.

7.5.3 While waiting to provide an additional Sample the Athlete shall remain under
continuous observation by a DCO/Chaperone.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 20 of 27
 7.5.4 The Athlete shall be encouraged not to hydrate excessively, since this may
delay the production of a suitable Sample.

7.5.5 When the Athlete is able to provide an additional Sample, the DCO shall repeat
the procedures for collection of the Sample (7.1 to 7.4).

7.5.6 Whenever possible, provision of additional Samples should be observed by the

same Witness as for the first. However, a change of Witness shall not
invalidate the Sample collection procedure.

7.5.7 The Witness shall sign the relevant documentation to verify that he/she
witnessed Sample provision in accordance with procedures.

7.5.8 The DCO should ensure that Samples provided by the same Athlete can be
linked through the documentation and that the laboratory is informed which
the initial Sample is. All Samples shall be sent to the laboratory for analysis
with all related paperwork.

7.6 Paperwork

[7.6 Comment: See WADA’s standardized Doping Control documentation for an example of
suitable documentation. See also the International Standard for Testing, 7.4.5 for minimum
requirements.]

7.6.1 If the Athlete provided more than one Sample and the Witness was not the
same individual that witnessed provision of the first Sample, all Witnesses shall
sign the Doping Control form.

7.6.2 If the Witness is unable to verify that he/she observed the passing of the
Sample, or reports unusual behavior by the Athlete, the DCO can require the
Athlete to provide a further Sample. This must be documented, and all
Samples collected sent to the laboratory for analysis.

7.6.3 The DCO shall request the Athlete to provide information on all medications
and/or supplements taken within the time period specified on the Doping
Control form.

[7.6.3 Comment: The recommended period for medication information is 7 days.]

7.6.4 The DCO should check all information on the form and fill in any incomplete
areas in view of the Athlete. The Witness then signs to confirm that the Sample
collection was conducted in accordance with procedures.

7.6.5 The Athlete and the Athlete’s Representative, if present, should be invited to
check that all information on the form accurately reflects the details of the
Sample Collection Session. The Athlete shall be invited to complete the
comments section of the form if he/she has any concerns or comments

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 21 of 27
 regarding the procedure. If there is insufficient space on the form, the Athlete
should be invited to complete a supplementary report form.

7.6.6 The Athlete’s Representative, if present shall sign the Doping Control Form.

7.6.7 The Athlete and DCO shall then sign the Doping Control Form.

7.6.8 The DCO must give a full copy of the form to the Athlete.

7.6.9 Unless also required to provide a blood Sample, the Athlete is then free to
leave the Doping Control Station.
[7.6.9 Comment: If an Athlete is also required to provide a blood Sample, and the Doping Control
form records both blood and urine collection, the paperwork will not be fully completed until after
collection of both blood and urine Samples.]

7.7 Sample Storage

7.7.1 The DCO has the responsibility for ensuring, in accordance with the ADO
criteria for Sample storage, that all Samples are stored in a manner that
protects their identity, integrity and security whilst in the Doping Control
Station.

7.7.2 Samples must not be left unattended, unless they are locked away in a
refrigerator or cupboard, for example. Access should be restricted to
authorized personnel.

7.7.3 Where possible, Samples should be stored in a cool environment. Warm

conditions should be avoided.

7.7.4 The DCO shall accurately complete appropriate documentation for each
transport bag/container to ensure that the laboratory can verify the contents of
the bag/container.

7.7.5 The DCO shall follow the ADO’s system to ensure that, where required,
instructions for the type of analysis to be conducted are provided to the
laboratory.

7.7.6 The DCO shall complete the laboratory advice form/Chain of Custody form. The
laboratory copy of this form(s) and the laboratory copy of the Doping Control
form should be placed in the transport bag with the Samples, and sealed,
preferably in the presence of a second person. Documentation identifying the
Athlete shall not be included with the Samples.

7.7.7 If relevant, the DCO should record the times the transport bag is opened and
re-sealed on the laboratory advice form or Chain of Custody form.

7.7.8 The DCO shall keep the Samples secured and under his or her control until
they are passed to the courier.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 22 of 27
8. Transport of Samples and Documentation

8.1 Transportation of Samples

8.1.1 Samples shall be shipped to the WADA accredited laboratory as soon as

practical, and wherever possible on the day of collection.

8.1.2 Samples may be taken directly to the laboratory by the DCO, or handed over
to a third party for transportation. This third party must document the Chain of
Custody of the Samples. If an approved courier company is used to transport
the Samples, the DCO should record the waybill number.

8.2 Hand-over of Samples to the laboratory

8.2.1 Laboratories are required to document receipt and the subsequent Chain of
Custody of Samples. Samples are reviewed for evidence of tampering or
damage, and stored in appropriate conditions in accordance with the
International Standard for Laboratories.

8.3 Documentation

8.3.1 All documentation relevant to the Sample Collection Session should be

forwarded to the ADO by the approved method as soon as possible after
Sample collection.

9. Modifications for Minors and Athletes with a Disability

9.1 Overview

9.1.1 Minors or Athletes with specific types of disability may require modifications to
the Sample collection procedure. The modifications outlined below do not
affect the integrity of the Sample collection process.

9.1.2 The ADO has responsibility for ensuring, when possible, that the DCO has any
information and specialised Sample Collection Equipment necessary to conduct
a Sample Collection Session with an Athlete with a disability requiring
assistance during Sample provision. The DCO shall have the authority to make
modifications as the situation requires, in accordance with these guidelines.

9.1.3 In some cases, with the agreement of the DCO, the Athlete may designate the
Athlete Representative, or the DCO/Chaperone to assist with the Sample
collection process.

9.1.4 Any modifications made to the standard Sample collection procedure shall be
documented by the DCO.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 23 of 27
Modifications may be introduced in the case of the following Athletes:

9.2 Minors

9.2.1 Minors may, at their request, be accompanied by an Athlete Representative at

all times during the Sample collection procedure, including in the toilet area.
However, the Athlete Representative shall not witness the passing of the
Sample, unless requested to do so by the Athlete. The objective is to ensure
that the Witness is observing Sample provision correctly. Even if the Minor
declines a representative, the ADO, DCO or Chaperone, as applicable, should
consider whether a third party ought to be present during notification of and/or
collection of the Sample from the Athlete.

9.2.2 If a Minor declines to have a representative present during the Sample

Collection Session, this shall be clearly documented by the DCO. Failure to do
so does not invalidate the test. If a Minor declines the presence of a
representative, the representative of a DCO/Chaperone must be present.

9.2.3 The Athlete Representative or the DCO should explain the Doping Control
documentation to the Athlete, if necessary.

9.2.4 If the Minor is accompanied for the verification of procedure (signing of the
Doping Control form) the Athlete Representative should sign in addition to the
Athlete.

9.3 Athletes with a disability

9.3.1 In planning and arranging Sample collection, the ADO and DCO shall consider
whether there will be any Sample collection for Athletes with disabilities that
may require modifications to the standard procedures for notification or Sample
collection, including Sample Collection Equipment and facilities. For e.g.
Athletes with Cerebal Palsy and/or significant lack of co-ordination may require
the use of larger collection vessels, if available.

9.3.2 An Athlete with an intellectual, physical or sensorial disability can be assisted by

the Athlete Representative or Sample Collection Personnel during the Sample
Collection Session where authorised by the Athlete and agreed to by the DCO.

9.3.3 The DCO shall have the authority to make modifications as the situation
requires when possible and as long as such modifications will not compromise
the identity, security or integrity of the Sample. All modifications must be
recorded.

9.3.4 Athletes with visual impairment may be accompanied by an Athlete

Representative at all times during the Sample collection procedure, including in
the toilet area. However, the representative shall not witness the passing of the
Sample. The objective is to ensure that the Witness is observing Sample

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 24 of 27
 provision correctly. The Athlete Representative or the DCO should read the
Doping Control documentation to the Athlete, if necessary.

9.3.5 Blind Athletes must be accompanied for the verification of procedure (signing of
the Doping Control Form), and the Athlete Representative should sign on behalf
of or in addition to the Athlete.

9.3.6 Athletes with an intellectual disability should be accompanied by an Athlete

Representative at all times during Sample collection procedure, including in the
toilet area. However, the representative shall not witness the passing of the
Sample. The objective is to ensure that the Witness is observing Sample
provision correctly.

9.3.7 The Athlete Representative or the DCO should read and/or explain the Doping
Control documentation to the Athlete, if necessary.

9.3.8 Athletes with an intellectual disability should be accompanied for the verification
of procedure (signing of the Doping Control Form), and the Athlete
Representative should sign on behalf of or in addition to the Athlete.

9.4 Athletes using condom drainage or indwelling catheter drainage

9.4.1 Athletes shall remove, or supervise the removal of, the existing collection bag
and drain the system so that a fresh Sample can be obtained.

9.5 Athletes who self-catheterize

9.5.1 Athletes may use their own catheter to provide a Sample (this catheter should
be produced in tamper-evident wrapping), or use one provided at the Doping
Control Station, if available.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 25 of 27
Appendix 1: Chaperone Training Guidelines

A. Procedure for training notifying Chaperones

1. The notifying Chaperones should meet the DCO at the Doping Control Station prior
to the start of the Event to receive training, instruction, credentials and
assignments, as well as to complete a confidentiality agreement.

2. The DCO shall first ensure that the notifying Chaperones meet the relevant criteria
as specified by the ADO and are fit for duty. If not, alternative Chaperones shall
be found.

3. The DCO shall specifically ask the notifying Chaperones if they have any conflict of
interest, such as involvement with any Athlete that might be tested. If so,
alternative Chaperones shall be found.

4. The DCO should ensure that all notifying Chaperones have a watch, and all staff
should synchronize their watches.

5. The DCO shall review or arrange for the review of the notification and escorting
procedure with the notifying Chaperones. (6.1/6.2) The explanation should include
the purpose of the Chaperone role, and what to do if problems are encountered.
The DCO should make it clear that a Chaperone should ask for assistance from the
DCO if they are not sure how to proceed at any time.

6. The DCO should demonstrate the notification procedure by means of role-play,

should observe the Chaperone practice at least once, and point out mistakes as
well as providing praise.

7. The DCO shall inform the Chaperones that any strange behavior by Athletes, such
as ingestion of unknown substances, or evasion, shall be discretely reported to the
DCO upon arrival at the Doping Control Station.

8. The DCO should encourage questions from the Chaperones.

9. The DCO should arrange a location and time for the Chaperones to receive
information specific to the Athlete they will be notifying.

NOTE: whenever possible, notifying Chaperones should be assigned to Athletes of the

same gender.

10. Notifying Chaperones should then sign the relevant agreement which should as a
minimum require a commitment to confidentiality and outline a code of conduct.
The form should also require the Notifying Chaperone to provide their contact
details and date of birth.

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 26 of 27
 11.The Chaperones should, where possible, have an opportunity to assess the
location and plan the approach and timing of notification, taking into account the
specific circumstances of the session.

12.The DCO should provide guidelines as to the Chaperone’s responsibilities after the
Athlete has arrived at the Doping Control Station (i.e. whether they are free to
leave, or have further responsibilities).

B. Procedure for training witnessing Chaperones

Ideally, witnessing Chaperones will have prior experience, and will not be trained on-
site.

1. The witnessing Chaperones should meet the DCO at the Doping Control Station
prior to the start of the Event to receive training, instruction, credentials and
assignments, as well as to complete the confidentiality agreement. Training should
be separate from that of the Notifying Chaperones.

2. The DCO shall first ensure that the witnessing Chaperones meet the relevant
criteria as specified by the ADO and are fit for duty. If not, alternative Chaperones
shall be found.

3. The DCO shall specifically ask the Chaperones if they have any conflict of interest,
such as involvement with any Athlete that might be tested. If not, alternative
Chaperones shall be found.

4. The DCO shall review, or arrange the review of, the specific procedure for
observation of Sample provision (7.2).

5. Witnessing Chaperones should also be briefed about any sensitivities, and any
potential scenarios which might be encountered.

6. The DCO should encourage questions from the Chaperones.

7. Witnessing Chaperones should then sign the relevant agreement which should as
a minimum require a commitment to confidentiality and outline a code of conduct.
The form should also require the Witnessing Chaperone to provide their contact
details and date of birth.

8. The DCO should provide guidelines as to the Chaperone’s responsibilities after the
Athlete has provided the Sample at the Doping Control Station (i.e. whether they
are free to leave, or have further responsibilities).

© WADA – GUIDELINE FOR URINE SAMPLE COLLECTION Version 5.1 –August 2010

Page 27 of 27